Anne Dompmartin
Anne Dompmartin
Diagnosis and management of infantile hemangiomas: tremendous advances over the last 15 years [0.03%]
婴幼儿血管瘤的诊断和治疗：过去15年的巨大进展
Dorine Canu,Sorilla Mary-Prey,Christine Leauté-Labreze
Dorine Canu
Infantile hemangioma (IH) is the most common benign vascular tumour in infants. Clinically, the lesion may have a superficial (red) and/or deep (flesh-coloured - underlying bluish appearance) component and may be located in all areas of the...
Professor Lionel Collet,Professor Pierre Cochat
Professor Lionel Collet
French evaluation of innovative health technologies: Early access and fundings [0.03%]
法国卫生技术评估机构的早期准入和资金情况分析
Capucine Serain,Sylvie Chevret,Yann Chambon et al.
Capucine Serain et al.
Background: To accelerate the availability of innovative healthcare technologies for patients with the potential for significant clinical benefits in a context of high unmet needs, derogatory programs have been elaborated...
French reimbursement of health technologies: assessment is at the heart of the procedure [0.03%]
法国的卫生技术报销：评估是程序的核心
Cédric Carbonneil,Corinne Collignon,Hubert Galmiche et al.
Cédric Carbonneil et al.
Background: In France, health technologies can be reimbursed by the national health insurance system. However, not all are eligible, and several steps are required. This article aims at deciphering the various procedures ...
Health Technology Assessment in Europe: a comparison of organizations and introduction to the European regulation [0.03%]
欧洲卫生技术评估组织的比较及其监管政策介绍
Judith Fernandez,Paul de Boissieu,Margaret Galbraith
Judith Fernandez
Health Technology Assessment (HTA) is a multidisciplinary process that evaluates the medical, social, economic, legal, and ethical aspects of health technologies to determine their value throughout their lifecycle. With rising healthcare co...
Maxence Lyonnet,Robert Gelli,Hubert Galmiche
Maxence Lyonnet
The HAS is unique in France due to its status as an independent public authority. Its closest equivalent is the National Institute for Health and Care Excellence (NICE) in England and Wales. It stands out from other French health agencies b...
The French way of HTA: between scientific rigour, independence and transparency [0.03%]
法国的卫生技术评估：科学严谨性、独立性和透明度之间的平衡
Joachim Baba,Nathan Guerrier,Irena Guzina et al.
Joachim Baba et al.
Context: The Haute Autorité de Santé (HAS) is an independent body responsible for advising the government on the appropriateness of national funding for healthcare technologies and interventions. To fulfil this role, HA...
Sophie Blanchard,Valérie Lindecker-Cournil,Bertrand Musetta et al.
Sophie Blanchard et al.
Heath Technology Assessment (HTA) is mainly used for reimbursement/disinvestment and access to innovation purposes. In addition, HTA is a useful tool to promote appropriateness of care, as it describes the updated level of validation of ass...
Patrick Berche
Patrick Berche
The occurrence of laboratory-associated infections, which are caused by the handling of human or animal pathogens, represents a significant threat to the health and safety of laboratory workers and the general population. Such risks are pre...